Maraviroc intensification of cART in patients with suboptimal immunological recovery: a 48-week, placebo-controlled randomized trial

File: CCR5+ and CXCR4+ CD4+ and CD8+ T cells. This SPSS file contains the percentage of CCR5+ and CXCR4+ CD4+ and CD8+ T cells at various time points during the MIRS trial. Please see the 'variable view' of the SPSS file and the 'methods' section of the paper for more information. We have used SAS software for our analyses.

数据集文件：CCR5阳性及CXCR4阳性的CD4+与CD8+ T细胞。本SPSS（Statistical Package for the Social Sciences）格式文件收录了MIRS试验期间不同时间点下，CCR5阳性及CXCR4阳性的CD4+与CD8+ T细胞的占比数据。如需获取更多详细信息，请查阅该SPSS格式文件的「变量视图」以及对应论文的「方法学章节」。本次数据分析采用SAS（Statistical Analysis System）软件完成。